VEriciguat NItroglycerin Clinical IntEraction (VENICE): a phase 1, multicenter, randomized, placebo-controlled, double-blind group-comparison study in patients with stable coronary artery disease to evaluate tolerability and blood pressure effects of nitroglycerin after pre-treatment with multiple oral doses of vericiguat – SocraTec R&D – Concepts in Drug Research and Development

About Us
Clinical Pharmacology Unit
Services
Expertise
Clinical Development

Career
Contact
Imprint
Data Policy

News
Libraries
Services
Expertise
Clinical Unit
Clinical Development
About Us
Proband sein
in Erfurt

News

Meet us at AGAH Early Phase discussion forum in Bonn

Meet us at BIO-EUROPE in Munich, Germany

5th GBHI Conference Report now published

We celebrate: 25 successful years of SocraTec R&D

SocraMetrics now offers full-scope Pharmacovigilance Services!

More...

Contact
Data Policy
Imprint

Headquarters • Im Setzling 35 • 61440 Oberursel
Clinical Pharmacology Unit • Mainzerhofplatz 14 • 99084 Erfurt

Phone • +49 (0) 6171 58 57 1-0
E-Mail • info @socratec-pharma.de

Supported by the Free State of Thuringia and the European Social Fund
Funding: English course for employees

Headquarters

Im Setzling 35
61440 Oberursel
Germany

Phone +49 (0) 6171 58 57 1-0
Fax +49 (0) 6171 58 57 25

info@socratec-pharma.de
www.socratec-pharma.de

Clinical Pharmacology Unit

Mainzerhofplatz 14
99084 Erfurt
Germany

Phone +49 (0) 361 60 20 5-0
Fax +49 (0) 361 60 20 5-25

Supported by the Free State of Thuringia and the European Social Fund
Funding: English course for employees

Proband werden

Klinische Forschung und medizinischer Fortschritt sind ohne freiwillige Probanden, die an klinischen Studien teilnehmen, nicht möglich. Leisten Sie einen wichtigen Beitrag bei der Entwicklung von neuen und besseren Medikamenten und Therapien!

Werden Sie Proband bei SocraTec!

All fine on single